ACHILLION PHARMACEUTICALS INC 4/A
4/A · ACHILLION PHARMACEUTICALS INC · Filed Dec 5, 2014
Insider Transaction Report
Form 4/AAmended
Apelian David
EVP and Chief Medical Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2014-12-02+175,000→ 175,000 totalExercise: $13.24Exp: 2024-12-02→ Common Stock (175,000 underlying)
Footnotes (2)
- [F1]Table II, column 5 of the Form 4 filed on December 4, 2014 (the "Original Form 4") inadvertently reported a disposition of options. This amendment is being filed solely to correct Table II, column 5 to show an acquisition of options. Except for the foregoing, no new or revised transactions or holdings are being reported by this amendment, and all other information reported in the Original Form 4 remains the same.
- [F2]This option grant vests as to 25% of the shares on the first anniversary of the date of grant and as to an additional 6.25% at the end of each three month period thereafter.